INVOKANA

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug INVOKANA contains one active pharmaceutical ingredient (API):

1 Canagliflozin UNII 0SAC974Z85 - CANAGLIFLOZIN

Canagliflozin is an orally-active inhibitor of SGLT2. The SGLT2 transporter, expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. By inhibiting SGLT2, canagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose (RTG). Read about Canagliflozin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
INVOKANA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BK02		A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
Discover more medicines within A10BK02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 514514110027102, 514514110027202, 514514110027302, 514514110027402
Country: CA	Health Products and Food Branch	Identifier(s): 02425483, 02425491
Country: EE	Ravimiamet	Identifier(s): 1633407, 1633418, 1633429, 1633430, 1633441, 1633452, 1633463, 1633474
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 113884002, 113884006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 129010, 135362, 458746, 547129
Country: FR	Base de données publique des médicaments	Identifier(s): 64292898, 67448256
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 240884, 240887, 376671, 379898, 381410
Country: HK	Department of Health Drug Office	Identifier(s): 63499, 63500, 66454, 66455
Country: IE	Health Products Regulatory Authority	Identifier(s): 13489, 13490, 29007, 47851, 47858
Country: IT	Agenzia del Farmaco	Identifier(s): 043145010, 043145022, 043145034, 043145046, 043145059, 043145061, 043145073, 043145085
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1072119, 1072120, 1072121, 1072122
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 115398, 115401
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100306753, 100306782
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60447001, W60447002, W60447003, W60447004, W60448001, W60448002, W60448003, W60448004
Country: SG	Health Sciences Authority	Identifier(s): 14506P, 14507P
Country: US	FDA, National Drug Code	Identifier(s): 50090-4364, 50090-5033, 50090-5034, 50458-140, 50458-141, 55154-1425, 55154-1426